News Medical on MSN1h
Breakthrough in gene-editing with Cas12a for modeling human diseasesAustralian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.
Pharmaceutical Technology on MSN18h
NHS England to offer Casgevy for sickle cell disease patientsThe UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...
Animal Planet HQ on MSN18h
The Woolly Mammoth Comeback: Scientists Are Closer Than EverIn the rapidly evolving field of genetic engineering, few names resonate as profoundly as George Church, a geneticist at Harvard University. Known for his groundbreaking work in genomics, Church has ...
People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...
News Medical on MSN17h
Researchers create random versions of human genomes to study diseaseThe most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more resilient to significant structural changes than was previously thought.
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
One sickle cell patient told ITV News the new gene therapy being rolled out for use on the NHS means they "finally have something to look towards". | ITV National News ...
Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...
Tata Technologies Ltd., incorporated in the year 1994, is a Small Cap company (having a market cap of Rs 31,526.53 Crore) operating in IT Software sector. Tata Technologies Ltd. key Products/Revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback